United Therapeutics (UTHR) loses 55 cents to $54.64 and a 9200-lot of Nov 57.5 calls trades on the stock for $2.50 per contract on PCoast. Hearing initiator bought and the hefty premium purchase is tied to 390K shares at $54.50. Total volume in the Nov 57.5 call on UTHR is 10,150 against 227 in open interest. 3o-day at-the-money implied volatility is up 15 percent to 31.5. Shares of the Silver Spring, MD biotech have seen uninspired action in recent weeks, since hitting a 52-week high of $56.78 on 8/15. Earnings will be reported again in late-October and inside of the November expiration. Shares jumped 4.6 percent on 7/26 when the company last released results.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.